Browse the evidence

Personalized weight management strategies should account for individual metabolic and hormonal differences.

Practitioners should consider individual metabolic profiles when designing weight management plans.

Precision approaches can help tailor weight management plans to an individual's unique metabolic profile.

Implementing precision nutrition can enhance the effectiveness of weight management strategies.

Extreme dieting trends have negative impacts on health and eating behaviors.

Practitioners should be cautious of recommending extreme diets due to potential health risks.

Moderation in food choices can be promoted without moralizing through systems like the 'traffic light' system.

Practitioners can utilize moderation-focused approaches to improve dietary habits without inducing guilt.

HFLC diets reduced fat mass (FM) compared to MM diets with a mean difference of -2.88 kg.

Practitioners may consider HFLC diets for clients aiming to reduce fat mass.

Increasing plant protein intake has positive implications for longevity.

Encouraging higher plant protein consumption could be beneficial for health and longevity.

Body weight after one year decreased from 127.3 kg to 122.2 kg (p < 0.001).

Practitioners can expect significant weight loss in patients participating in this program.

Average hemoglobin A1c value decreased from 5.8% to 5.6% in all patients (p < 0.001) and from 6.6% to 6.2% in patients with type 2 diabetes (p < 0.001).

Practitioners can expect improvements in glycemic control in patients participating in this program.

Clinical obesity conferred elevated risks of incident diabetes (AHR, 6.11), cardiovascular events (AHR, 5.88), and all-cause mortality (AHR, 2.71) compared with no obesity.

Clinical obesity significantly increases the risk of serious health conditions, necessitating proactive management.

A model to prescribe exercise dose that considers various cardiovascular risk factors can improve individual outcomes from cardiac rehabilitation.

Practitioners should consider a comprehensive assessment of cardiovascular risk factors when prescribing exercise in cardiac rehabilitation.

Evidenzbasierte Therapieoptionen bei AP-assoziierter Gewichtszunahme umfassen Lebensstilveränderungen, diätetische Maßnahmen, Bewegungstherapie, Dosisreduktion, Umstellung und Beendigung der Medikation sowie zusätzliche Therapien.

Implementing lifestyle and dietary changes can be effective in managing weight gain from medications.

The European Society of Cardiology guidelines provide up-to-date recommendations for managing diabetes and cardiovascular disease.

Practitioners should refer to these guidelines for current management strategies.

The correlation between lower-extremity muscle strength and exercise capacity is stronger in patients with diabetes mellitus compared to those without.

Emphasizing muscle strength training may be particularly beneficial for diabetic patients with CVD.

The tailored nutrition intervention resulted in higher total daily energy and protein intake levels.

Implementing tailored nutrition protocols can significantly enhance energy and protein intake in recovery.

Fewer participants in the on-paper group reported to have experienced significant weight loss in their adult life (70.0% vs 100%, p = 0.001).

Practitioners may consider that individuals who prefer paper surveys may have less successful weight loss experiences.

The digital group reported significantly greater weight loss maintenance (86.5% vs 43.8% of the initial weight loss, p = 0.008).

Practitioners may find that digital engagement leads to better weight loss maintenance.

Functional training is defined as a physical interventional approach that enhances human performance according to individual goals.

This definition can guide practitioners in designing functional training programs.

Caffeine consumption of 3-6 mg/kg body weight, taken 60 minutes before exercise, enhances endurance, alertness, and perceived effort in cycling.

Take 3-6 mg of caffeine per kg of body weight about 60 minutes before your ride. This is one of the most effective legal ways to boost endurance and focus. Start with the lower end if you are sensitive.

Carbohydrate intake of 30-90 g/hour during exercise fuels prolonged activity and delays fatigue by maintaining blood glucose and muscle glycogen levels.

For rides longer than an hour, consume 30-90g of carbohydrates per hour. Use a mix of glucose and fructose for better absorption. Practice your nutrition strategy in training to avoid stomach issues.

Creatine supplementation significantly improves anaerobic power (Wingate peak and mean power) regardless of whether the individual is performing resistance training or non-resistance training.

Take creatine daily to boost your high-intensity performance (like sprinting or sports). You do not need to be in a gym or doing weights to get these power benefits.

Tirzepatid (GIP/GLP-1 agonist) provides superior weight loss and glycemic control compared to Semaglutid in patients with Type 2 Diabetes and Obesity.

If oral medications and lifestyle changes are insufficient, Tirzepatid (10-15mg weekly) is currently the most effective pharmacological option for weight loss and blood sugar control in Type 2 Diabetes, outperforming Semaglutid. Discuss this with your doctor to see if it's appropriate for your specific health profile.

Metabolic (bariatric) surgery is indicated for Type 2 Diabetes patients with BMI > 30 kg/m2 and can lead to significant diabetes remission.

If you have Type 2 Diabetes and a BMI over 30, metabolic surgery is a medically indicated option that can lead to diabetes remission in 45-95% of cases. It requires lifelong monitoring but offers superior outcomes compared to medication alone.

Replacing saturated fatty acids (SFA) with polyunsaturated fatty acids (PUFA), specifically linoleic acid (LA) found in seed oils, reduces cardiovascular disease (CVD) risk and is safe for long-term consumption.

Follow established dietary guidelines: limit saturated fats (like butter and lard) and replace them with unsaturated fats, including seed oils (like soybean, corn, or canola oil), to support heart health. The scientific consensus supports the safety and benefit of these oils.

Weekly subcutaneous tirzepatide (5-15 mg) produces significant, dose-dependent weight loss (-15% to -21%) and improves cardiometabolic markers in adults with overweight/obesity, including those with type 2 diabetes.

If you have obesity or overweight with related health issues, weekly tirzepatide injections, combined with diet and exercise, can lead to significant weight loss (15-21%) and improve heart and metabolic health. Start with a low dose to minimize side effects, and gradually increase it as tolerated.